BioCare Introduces Quality and Regulatory Consultancy Service

QRCare aims to help manufacturing partners in a variety of compliance and regulatory needs

Specialty therapy distributor BioCare has announced the launch of QRCare, a quality and regulatory consultancy service that provides BioCare‘s partners with the support needed to develop and maintain strategic quality and regulatory efforts.

QRCare offers assistance to customers throughout their quality and regulatory journeys, whether they are establishing a system from the ground up, preparing for a supply chain inspection or implementing change control, the company reports.

QRCare is led by industry experts Kathleen Hopping, vice president of regulatory affairs, and Peggy Yena, vice president of quality. “The patient experience drives everything we do,” said Hopping. “By offering much-needed assistance to specialty drug manufacturers and partners, we are ultimately enabling critically needed and potentially life-saving medications to be available to patient populations sooner.”

“Our goal is to be the most trusted quality and regulatory experts for our partners,” added Yena.

www.biocare-us.com